Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
4
×
national blog main
boston blog main
boston top stories
clinical trials
national top stories
deals
fda
new york blog main
new york top stories
san francisco blog main
san francisco top stories
wisconsin blog main
wisconsin top stories
abbvie
acorda therapeutics
alnylam pharmaceuticals
ambys medicines
amicus therapeutics
ampio pharmaceuticals
ampyra
android
angelman syndrome
anthem blue cross and blue shield in ohio
apokyn
apomorphine
apple
aptar pharma
asthma
athenex
biofourmis
biomarin pharmaceutical
biotech
biovotion
bluebird bio
bluetooth
boston
boulder/denver blog main
boulder/denver top stories
cdc
What
help
4
×
patients
4
×
digital
drug
fda
medicare
acorda
analytics
approach
approved
aren’t
based
bio
biofourmis
copd
cope
data
developers
devices
disease
drugs
employs
episodes
friday
gene
gets
globally
group
hauls
health
imminent
insurer
late
long
looms
meant
medications
million
moves
new
Language
unset
Current search:
help
×
patients
×
" life sciences "
×
@xconomy.com
3 years ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com
5 years ago
Acorda Gets FDA Nod For New Parkinson’s Drug, But Rival Looms
@xconomy.com
5 years ago
Ohio Insurer Turns to Propeller Health for Digital Approach to COPD
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More